Replies to post #470215 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

The only one that would matter is the second one: Full regulatory submission of
blarcamesine in Europe (EMA)

Chances of it happening in 2024-2025 only 50-50.

Bourbon...on my...

Can you elaborate on the timing a little ??I read EMA was ready to move-comment soon (Q4 24 -Q1 25) w/some kind of testing plan.